Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

EHC vs ITGR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EHC Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 6–4 Matrix Metrics)

EHC Overall Winner 6-Pillar Tally: EHC 5 – 1 ITGR Matrix Metrics: EHC 6 – 4 ITGR

As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over Integer Holdings Corporation (ITGR) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas ITGR carries 65.5/100 (BUY) at $126.97 (18.5x Forward P/E, 9.8% operating margin).

  • Composite vs. Pillar Nuance: While ITGR currently prints a higher short-term Unified Composite Score (65.5/100 BUY vs. EHC 52.0/100 HOLD), EHC captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (18.4% vs. 9.8% operating margin) and revenue trajectory (+8.9% vs. -3.9% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EHC vs ITGR
EHC NYSE Head-to-Head Winner
Encompass Health Corporation Common Stock
Services-Hospitals
$133.65
+1.04% 1D
Market Cap $13.0B
TTM Revenue $6.34B
Forward P/E 19.4x
Beta / 30D Vol -0.10β · 40% Vol
Unified Composite Score
52.0 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 50
RSI-14: 49.8 · SMA20: $135.78 · SMA50: $128.15
ITGR NYSE
Integer Holdings Corporation
Electromedical & Electrotherapeutic Apparatus
$126.97
+0.21% 1D
Market Cap $4.3B
TTM Revenue $1.83B
Forward P/E 18.5x
Beta / 30D Vol 0.53β · 2% Vol
Unified Composite Score
65.5 / 100 BUY
Tech 59.0 Fund 59.0 Flow 60.0 Mom 58.9
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 63
RSI-14: 63.2 · SMA20: $126.62 · SMA50: $126.47

6-Pillar Scorecard Institutional Category Breakdown (EHC 5 – 1 ITGR)

Columns: Metric · EHC · ITGR
1. Valuation Multiples EHC
Forward P/E 19.4x 18.5x
Trailing P/E 21.2x 42.5x
PEG Ratio 0.41x 3.06x
EV / Revenue 2.5x 3.1x
2. Growth & Scale EHC
Revenue Growth (YoY) +8.9% -3.9%
Earnings Growth (YoY) +21.6% -61.3%
TTM Revenue (USD) $6.34B $1.83B
Market Cap $13.0B $4.3B
3. Profitability & Quality EHC
Gross Margin 44.1% 25.1%
Operating Margin 18.4% 9.8%
Net Profit Margin 10.2% 5.7%
Return on Equity (ROE) 25.1% 6.0%
4. Balance Sheet & Cash Flow EHC
Cash Generation (TTM) $457M $83M
Cash Flow Margin 7.2% 4.5%
Net Cash / Leverage $2.73B Net Debt (1.05x D/E) $1.33B Net Debt (0.78x D/E)
Dividend Yield 0.58% None (0.00%)
5. Options & Positioning ITGR
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 27.0% (8th %ile) 0.7% (<1st %ile)
Put/Call OI Skew 0.25x (Call-Skewed) 0.01x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat EHC
OpEx & R&D Intensity 25.7% of Rev ($1.63B) 15.3% of Rev ($279M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Care Facilities Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EHC (6) vs ITGR (4)
Institutional Metric EHC ITGR Criterion Row Edge
Market Capitalization
Scale
$13.0B $4.3B Larger Scale EHC
Trailing P/E Ratio
Valuation
21.2x 42.5x Lower Multiple EHC
Forward P/E Ratio
Valuation
19.4x 18.5x Lower Multiple ITGR
Revenue Growth (YoY)
Growth
+8.9% -3.9% Higher Growth EHC
Operating Margin (TTM)
Profitability
18.4% 9.8% Higher Margin EHC
Net Profit Margin
Profitability
10.2% 5.7% Higher Margin EHC
Return on Equity (ROE)
Capital Efficiency
25.1% 6.0% Higher ROE EHC
52-Week Range Position
Momentum
80% ($93–$144) 91% ($67–$133) Stronger Trend ITGR
Beta / 30D Volatility
Risk Regime
-0.10β · 40% Vol 0.53β · 2% Vol Lower Realized Risk ITGR
Unified Institutional Score
Composite Signal
52.0 / 100 (HOLD) 65.5 / 100 (BUY) Higher Composite ITGR
Trailing 12M Revenue (USD)
Operating Scale
$6.34B $1.83B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
44.1% 25.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.41x PEG · 2.5x EV/Rev 3.06x PEG · 3.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$457M ($2.73B Net Debt (1.05x D/E)) $83M ($1.33B Net Debt (0.78x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EHC +10.93 pp
EHC: +11.14% · ITGR: +0.21%
3M Horizon EHC +14.89 pp
EHC: +16.39% · ITGR: +1.5%
6M Horizon ITGR +7.18 pp
EHC: +33.94% · ITGR: +41.12%
1Y Horizon ITGR +60.69 pp
EHC: +26.97% · ITGR: +87.66%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period EHC Revenue ITGR Revenue EHC Op. Margin ITGR Op. Margin Margin Leader
FY2018 $4.28B $1.22B 13.0% 12.8% EHC
FY2019 $4.61B $1.26B 13.3% 12.5% EHC
FY2020 $3.57B $1.07B 15.8% 11.2% EHC
FY2021 $4.01B $1.22B 13.9% 11.1% EHC
FY2022 $4.35B $1.33B 12.4% 8.5% EHC
FY2023 $4.80B $1.56B 7.3% 10.5% ITGR
FY2024 $5.37B $1.72B 8.5% 12.1% ITGR
FY2025 $5.94B $1.85B 9.5% 11.9% ITGR

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EHC CONSOLIDATION
73d in phase · OBV DISTRIBUTION
Current IV 27.0%
IV Percentile 8th %ile
Put/Call OI Skew 0.25x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact EHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ITGR CONSOLIDATION
71d in phase · OBV NEUTRAL
Current IV 0.7%
IV Percentile <1st %ile
Put/Call OI Skew 0.01x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ITGR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EHC Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $13.0B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 25.7% of Rev ($1.63B)
90D Engineering Disclosures 0 Published
ITGR Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $4.3B market capitalization and 9.8% operating margin.
OpEx & R&D Reinvestment 15.3% of Rev ($279M)
90D Engineering Disclosures 0 Published

Investor FAQ EHC vs ITGR Key Questions & Quantitative Answers

As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over Integer Holdings Corporation (ITGR) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas ITGR carries 65.5/100 (BUY) at $126.97 (18.5x Forward P/E, 9.8% operating margin). Composite vs. Pillar Nuance: While ITGR currently prints a higher short-term Unified Composite Score (65.5/100 BUY vs. EHC 52.0/100 HOLD), EHC captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (18.4% vs. 9.8% operating margin) and revenue trajectory (+8.9% vs. -3.9% YoY).

EHC leads the Growth & Scale pillar: EHC posts +8.9% YoY revenue growth and +21.6% YoY earnings growth on $6.34B TTM revenue (44.1% gross margin, 18.4% operating margin), compared with ITGR at -3.9% YoY revenue growth and -61.3% YoY earnings growth on $1.83B TTM revenue (25.1% gross margin, 9.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), EHC cumulative revenue shifted +38.8% while ITGR shifted +51.6%. In operating R&D and SG&A reinvestment, EHC deploys 25.7% of Rev ($1.63B) (0 90-day corporate R&D disclosures) versus 15.3% of Rev ($279M) (0 disclosures) for ITGR.

EHC screens cheaper on headline valuation multiples. EHC trades at 19.4x Forward P/E, 21.2x Trailing P/E, 0.41x PEG, and 2.5x EV/Revenue (7.2% FCF margin), whereas ITGR trades at 18.5x Forward P/E, 42.5x Trailing P/E, 3.06x PEG, and 3.1x EV/Revenue (4.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EHC (25.1% ROE) versus ITGR (6.0% ROE) capital efficiency.

In options market volatility and institutional positioning, EHC carries 27.0% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.10β · 40% Vol realized risk). By comparison, ITGR carries 0.7% implied volatility (<1st %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.53β · 2% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.